Omeros (OMER) Net Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -206.73% |
| Dec 31, 2025 | 1,318.95% |
| Sep 30, 2025 | 121.53% |
| Jun 30, 2025 | -376.19% |
| Mar 31, 2025 | -54.18% |
| Dec 31, 2024 | 413.69% |
| Sep 30, 2024 | -307.27% |
| Jun 30, 2024 | 105.48% |
| Mar 31, 2024 | 77.59% |
| Dec 31, 2023 | -197.91% |
| Sep 30, 2023 | 766.51% |
| Jun 30, 2023 | 138.64% |
| Mar 31, 2023 | 94.66% |
| Dec 31, 2022 | -202.38% |
| Sep 30, 2022 | 2,440.05% |
| Jun 30, 2022 | 105.63% |
| Mar 31, 2022 | -198.34% |
| Dec 31, 2021 | 1,866.46% |
| Sep 30, 2021 | -243.90% |
| Jun 30, 2021 | 349.42% |
| Mar 31, 2021 | 86.07% |
| Dec 31, 2020 | -155.33% |
| Sep 30, 2020 | 470.80% |
| Jun 30, 2020 | -227.76% |
| Mar 31, 2020 | 169.83% |
| Dec 31, 2019 | -218.50% |
| Sep 30, 2019 | 7,269.12% |
| Jun 30, 2019 | 96.24% |
| Mar 31, 2019 | -158.78% |
| Dec 31, 2018 | 3,302.08% |
| Sep 30, 2018 | -105.67% |
| Jun 30, 2018 | 176.83% |
| Mar 31, 2018 | -193.12% |
| Dec 31, 2017 | 200.34% |
| Sep 30, 2017 | -212.17% |
| Jun 30, 2017 | 323.35% |
| Mar 31, 2017 | 88.33% |
| Dec 31, 2016 | -241.43% |
| Sep 30, 2016 | 58.07% |
| Jun 30, 2016 | 1,033.07% |
| Mar 31, 2016 | -150.65% |
| Dec 31, 2015 | 138.98% |
| Sep 30, 2015 | -275.00% |
| Jun 30, 2015 | 3.04% |
| Mar 31, 2015 | 374.49% |
| Dec 31, 2014 | 49.43% |
| Sep 30, 2014 | -181.06% |
| Jun 30, 2014 | 218.24% |
| Mar 31, 2014 | -449.15% |
| Dec 31, 2013 | 141.34% |
| Sep 30, 2013 | -230.11% |
| Jun 30, 2013 | 282.01% |
| Mar 31, 2013 | -151.96% |
| Dec 31, 2012 | 107.41% |
| Sep 30, 2012 | 34.89% |
| Jun 30, 2012 | -174.50% |
| Mar 31, 2012 | 1,549.26% |
| Dec 31, 2011 | -221.12% |
| Sep 30, 2011 | 206.30% |
| Jun 30, 2011 | -62.99% |
| Mar 31, 2011 | 33.40% |
| Dec 31, 2010 | 725.97% |